Podcasts about Prostate cancer

Nutritional strategies for treating Barrett's EsophagusHow can my uncle mitigate the side effects of his Merkel cell carcinoma therapy?How long can I take strontium?Is beet root powder beneficial for nitric oxide production?

The best water filter?Even more on gadoliniumVagus nerve therapy benefitsWith so many benefits of drinking coffee, should I drink more of it instead of tea?Any update on Barrett's Esophagus?

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. It's the second-leading cause of cancer-related death for American men, behind lung cancer, according to the American Cancer Society.Wednesday on Midday Edition, we invite Jerry McCormick to tell the story of his own diagnosis and his efforts to spread awareness of the disease.Then, we get a medical perspective on prostate cancer, from getting screened to available treatments.Guests:Jerry McCormick, prostate cancer awareness advocateDr. Ramdev Konijeti, director of the Genitourinary Oncology Program at Scripps Cancer Center, surgeon with Scripps Clinic

Geo Espinosa, ND, LAc, CNS, a well-known naturopathic doctor specializing in urological health at NYU Langone Hospital, licensed acupuncturist, and certified Functional Medicine practitioner, discusses prostate health, including the latest advances in prostate cancer treatment and the importance of a balanced approach between natural and conventional medicine. Dr. Espinosa also highlights the upcoming Prostate Cancer Summit 2.0, scheduled for December 13th-17th, a free online event designed to provide comprehensive information on prostate cancer diagnosis, treatment, and management. The conversation covers PSA testing, new diagnostic tools, advanced treatment options like androgen deprivation therapy, and the benefits of exercise and diet in managing prostate health.

Geo Espinosa, ND, LAc, CNS, a well-known naturopathic doctor specializing in urological health at NYU Langone Hospital, and host of the upcoming Prostate Cancer Summit 2.0, scheduled for December 13th-17th, a free online event designed to provide comprehensive information on prostate cancer diagnosis, treatment, and management. 

A prostate cancer support group in Ardnacrusha is offering vital help to men and their families, thanks to the work of founder Tony Bridgeman, who set it up in April 2023. Among those involved is Phelim Warren, a cancer survivor whose own diagnosis came as a shock despite having no symptoms. His story highlights the importance of regular blood tests, early detection and open conversations around men's health. To find out more, Alan Morissey was joined by Tony Bridgeman and Pheilim Warren on Tuesday's Morning Focus. Join the prostate cancer support group here: https://www.facebook.com/groups/1380816599365491 Photo: (c) Clare fm/ Pheilim Warren/ logo from Prostate Cancer Support Group Ireland via Facebook.

Today, we'll be tackling the future of prostate cancer care. We'll be reflecting on what prostate cancer care means in practice, how the way we think about the disease is shifting, and must continue to shift in the years ahead. Scientific advances have transformed treatment in recent years, yet the lived reality of prostate cancer still extends far beyond the clinic. The disease reshapes daily life, and may leave men and their families grappling with difficult choices about how best to manage it.  Dr. Güneş Taylor is joined by three key voices at the centre of this story, following the prostate cancer journey from diagnosis through to long-term management, and asking how patients and clinicians can work together to re-think what patient-centred care could mean in the years to come. This episode is brought to you in collaboration with Bayer, part of their Prostate Cancer Perspectives series.  PP-UN-ONC-GB-0168. November 2025 References Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263 (Prostate cancer is the second most common cancer in men and the fifth leading cause of cancer death worldwide) James D, et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 2024;403(10437):1683–1722 (Each year, around 1.5 million men are diagnosed and nearly 400,000 lose their lives to the disease.1 And the numbers are rising. Diagnoses are projected to double from 1.4 million annually in 2020 to 2.9 million by 2040) Siegel RL, et al. Cancer statistics, 2022. Ca Cancer J Clin. 2022;72:7–33 (In the U.S., the proportion of men diagnosed with advanced-stage prostate cancer has doubled in recent years, due to increasing incidence of advanced-stage disease and changing guidelines regarding the prostate specific antigen screening test, implemented in the U.S. in 2012) Dodkins J, et al. Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population based evaluation. BMJ Oncology. 2025;4:e000643 (In England, nearly one in five men only receive a diagnosis once their cancer has spread) Calvo-Schimmel A, et al. Supportive care interventions and quality of life in advanced disease prostate cancer survivors: An integrative review of the literature. Can Oncol Nurs J. 2021;31(4):412-429 (Advanced prostate cancer is often associated with long-term challenges leading to greater levels of unmet needs in supportive care) Learn more about your ad choices. Visit podcastchoices.com/adchoices

On this week's news podcast, the former UK prime minister, David Cameron, calls for prostate cancer screening following his diagnosis. But does it really help to know you have the disease? Also, we find out about the DNA composition of the carbon-rich asteroid Bennu, the underlying cause of Santorini's recent earthquakes, and scientists discover where domestic cats came from... Like this podcast? Please help us by supporting the Naked Scientists

A panel of experts has recommended that screening for prostate cancer should be targeted only at men who are most at risk of developing the disease. Also: Downing Street has denied allegations that the Chancellor, Rachel Reeves, misled the public over the state of public finances in the run up to this week's Budget. And the UK has launched a bid to host the 2035 Women's World Cup, with 22 stadiums across the country potentially eligible.

One of Australia’s best-known and most colourful politicians, Barnaby Joyce, is quitting the National Party to sit as an independent—and he hasn't ruled out joining Pauline Hanson’s One Nation in the future. Sarah Ison joins Claire Harvey to unpack the shock defection, what Pauline Hanson sees in the firebrand former leader, and why Joyce isn't resigning his New England seat to trigger a by-election. Read more about this story, plus see photos, videos and additional reporting, on the website or on The Australian’s app. This episode of The Front is presented and produced by Claire Harvey and edited by Tiffany Dimmack. Our team includes Kristen Amiet, Lia Tsamoglou, Tiffany Dimmack, Joshua Burton, Stephanie Coombes and Jasper Leak, who also composed our music. See omnystudio.com/listener for privacy information.

World-renowned sexual health expert, Dr Chris Nelson, Chief of Psychology at Memorial Sloan-Kettering Cancer Centre, joins us in studio to run through the new Movember-supported "Guidelines for Sexual Health Care for Prostate Cancer Patients". A really helpful overview and structure for anyone working in this field, and for patients and their loved ones. Chris shares his 20-plus years of experience working in this field at one of the world's premier prostate cancer centres.Even better on our YouTube channel  Links:Movember Sexual Health Guidelines

A bin man from Dover with terminal cancer has been escorted to his wedding by a procession of refuse trucks.Stephen Addley's been told he has just months to live and one of his final wishes was to marry his fiancée and make memories with their one-year-old daughter.Also in today's podcast, we've got reaction to yesterday's budget after the chancellor announced £26 billion of tax hikes.Rachel Reeves has insisted the financial plans she announced in the Commons were based on her priorities.She also says the measures will give working class children the chance to have a fulfilling life.Hear from Andrew Tate and Rachel Emmerson from Chatham based accountants Kreston Reeves, Chatham and Aylesford MP Tris Osborne and the CEO of Canterbury based homeless charity Porchlight.Two men involved in a violent axe attack near Canterbury have been jailed for a total of 48 years.Police were called to reports of an assault involving people in two cars on the A2 near Wincheap in December last year.A driver involved in a serious crash on the A21 has called for safety improvements to be made.Conor Hardy says his vehicle aquaplaned at 70-miles-per-hour on the Tonbridge bypass following heavy rain, due to poor drainage. He's been speaking to reporter Elli Hodgson.A Medway man with incurable prostate cancer is among those calling on the health secretary to bring in a national screening programme.More than 120 MPs have also written to Wes Streeting after former Prime Minister David Cameron revealed he was treated for the disease last year. Hear from Paul Dennington who has raised more than £155,000 for Prostate Cancer UK.And, Ashford Designer Outlet has reached full occupancy for the first time since its 90 million pound extension opened six years ago.Two new fashion brands have opened at the shopping centre. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this plain language podcast, highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting 2025 are discussed. These insights come from the perspective of an expert patient and physician, both of whom have experience and expertise in the field of prostate cancer. This podcast is intended to broaden the reach of complex data and insights from ASCO 2025 to a broader audience, including non-specialists, helping enable better-informed treatment decisions between patients and healthcare professionals. This podcast is published open access in Oncology and Therapy and is fully citeable. You can access the original published podcast article through the Oncology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40487-025-00403-w. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The material in this podcast is included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. This podcast is intended for medical professionals.

To have Dr. Morse answer a question, visit: https://drmorses.tv/ask/ 00:00:00 - Intro - Books and New Courses! 00:05:36 - Stage 4 Cancer - Prostate 00:23:17 - Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) - Update with Eye Pictures 00:36:50 - Severe Bone Loss - Suicidal - Depression - Loss of Self 00:05:36 - Stage 4 Cancer - Prostate Everyone was stunned as my bone structure has regenerated and they don't know how to explain it! 00:23:17 - Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) - Update with Eye Pictures My 19-year-old collapsed on a volleyball court while playing. 00:36:50 - Severe Bone Loss - Suicidal - Depression - Loss of Self I have always dealt with depression and teeth problems.

 JR Richardson expressed overwhelming disbelief at his cancer-free diagnosis, stating he had been mentally prepared to die and was still recalibrating his mindset about surviving for his two children aged 15 and 17.Medical misdiagnoses occurred from 2018-2021 when JR's symptoms including pressure in his taint area were attributed to a fistula, fissure, and prostatitis rather than recognizing his PSA level of 21 as a cancer indicator.Healthcare providers failed to communicate the significance of JR's PSA level of 21, simply recommending a blood test without urgency, leading to a delayed diagnosis when his PSA reached 85.6 by the time of proper testing.Oncologist provided a grim prognosis of two to five years with palliative care options including abiraterone, steroids, and hormone blockers, offering no alternative treatment choices.JR declined conventional treatment initially, having been familiar with cannabis oil since Phoenix Tears and connected with Valerie Corral from WAMM, the first cannabis cooperative in the United States.Valerie Corral was identified as the pioneer who developed the 4:1 cannabis ratio and successfully sued the federal government after a farm raid, winning her case with Santa Cruz County support.Cannabis oil treatment began with JR taking a gram of oil he had made, but Corey Yelland advised switching to 4:1 ratio rectal administration for better effectiveness.PSA levels dropped dramatically from 85.6 to 29 within one month of starting 4:1 rectal cannabis treatment, and further decreased to 3.82 after receiving one hormone injection.Continued cannabis treatment brought PSA levels to normal range, with readings of 2.33, 1.82, and stabilizing around 1.72, demonstrating sustained improvement.Stanford Medical provided a second opinion contradicting the initial oncologist's palliative approach, recommending the Stampede Study protocol with pinpoint radiation on lymph nodes and two small spinal spots.Radiation treatment decision was made after consultation with a knowledgeable technician who explained advances in precision radiation technology, addressing JR's concerns about radiation damage based on his aunt's experience.Daily cannabis dosage consisted of at least one gram of CBG orally and two grams rectally with 10-20% lipid addition, plus additional oral THC, prioritizing survival over psychoactive effects.Valerie Corral's experience indicated that long-term cancer survivors in her practice had used both Western medicine and cannabis oil, influencing JR's decision to combine treatments.Recent scan results showed no metabolically active disease in previously affected areas including nodes and spine, confirming complete remission and validating the combined treatment approach. Visit our website: CannabisHealthRadio.comFind high-quality cannabis and CBD + get free consultations at MyFitLife.net/cannabishealthDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this JCO Precision Oncology Article Insights episode, Natalie DelRocco summarizes "Genomic Risk Classifiers in Localized Prostate Cancer: Precise but Not Standardized" by Góes et al. published on September 10, 2025. TRANSCRIPT Natalie DelRocco: Hello and welcome to JCO Precision Oncology Article Insights. I'm your host, Natalie DelRocco, and today we will be discussing the editorial "Genomic Risk Classifiers in Localized Prostate Cancer: Precise but Not Standardized." This editorial by Góes, Li, and Chehrazi-Raffle, and Janopaul-Naylor et al. describes genomic risk classifiers, or GRCs, for patients with localized prostate cancer. Like any risk prediction model, GRCs are intended to help identify groups of patients that may benefit from less intense or more intense anticancer therapy. Risk prediction tools can be difficult to bring into clinical practice; they require a lot of validation. And as the authors describe, GRCs in localized prostate cancer are no exception. The authors of this editorial contextualize an article by Janopaul-Naylor et al., which attempts to retrospectively explore the clinical use of three available GRCs for localized prostate cancer: Decipher, Oncotype DX, and Prolaris. Each of these three GRCs is being used in clinical practice currently. In the original article, all three GRCs were associated with less intense therapy being prescribed in practice. However, the editorial authors note that this is likely selection bias due to the observational nature of the study design. It is conceivable that GRCs were more likely ordered to make decisions for patients who were already thought to be good candidates for less intensive therapy. Another weakness of the retrospective study design is that patient level covariates known to be associated with clinical prognosis in localized prostate cancer, such as staging, Gleason score, prostate specific antigen, were unavailable. The authors note that sampling bias may also be an issue. Uninsured patients are not included in the original article, and therefore may impede the ability to make conclusions about the association of GRC use with income level. The editorial authors highlight important study findings as well as these limitations, such as the heterogeneity of interventions following GRC result return. The Prolaris GRC was found to be associated with more surgical interventions, while the Decipher GRC was associated with more androgen deprivation therapy plus radiation. Additionally, patients with active surveillance were more likely to have a GRC in general ordered. While these conclusions are very interesting, the editorial authors note that further exploration and validation, given the retrospective study design and limitations outlined, are needed to fully understand the impact of GRCs in the practice of treating localized prostate cancer. Thank you for listening to JCO Precision Oncology Article Insights. Don't forget to give us a rating or a review and be sure to subscribe so that you never miss an episode. You can find all ASCO shows atasco.org/podcasts. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.  Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

In today's episode, we had the pleasure of speaking with Daniel Spratt, MD, chair and professor in the Department of Radiation Oncology at Case Western Reserve University School of Medicine and a member of the Case Comprehensive Cancer Center in Cleveland, Ohio. Dr Spratt discussed key updates to the National Comprehensive Cancer Network (NCCN) Guidelines for prostate cancer, including how advances in molecular imaging, evolving systemic therapy options, and the integration of next-generation androgen deprivation therapy (ADT) are reshaping treatment recommendations across localized, recurrent, and advanced disease settings.

Michael Morris from MSKCC joins us for an in-depth review of ARPI development across the spectrum of prostate caner

In this episode of Agents of Nonprofit, I speak with Laurent Proulx, CEO of PROCURE, about the urgent need for proactive prostate cancer awareness, screening, and open conversation. With honesty and clarity, Laurent reinforces that early detection saves lives—and that vulnerability, not silence, is the real strength.Topics We Cover:Why family history (including mother's breast cancer) and ethnicity significantly increase prostate cancer riskHow Laurent's own diagnosis was discovered through an unexpected insurance medical examInside Procure's $10M biobank and its exclusive research advantages in QuebecHow data from 2,000 men is helping researchers understand which cancers become aggressiveThe role of AI in shaping the future of patient education and prostate cancer supportTo Learn More and Connect with Laurent:PROCURE.caPROCURE on InstagramSupport the show

In this EAU podcast episode, UROONCO PCa associate editor Dr. Pawel Rajwa (PL), talks to Prof. Thomas Zilli (CH) on local therapy in metastatic prostate cancer. This discussion was recorded at EMUC25. For more updates on prostate cancer, please visit our educational platform UROONCO PCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In this special session from the upcoming Prostate Summit 2.0, Dr. Eric Zielinski sits down with Dr. Geo for a rare, vulnerable and informative conversation about the why behind his life's work in prostate cancer care.Key PointsThe emotional and spiritual side of working with thousands of menWhy your why matters more than the diet, protocol, or treatment choiceThe 3 buckets of prostate cancer and why care must be personalizedHis 4 pillars of healing: lifestyle, nutrition, fitness, and stress masteryHow fasting, cruciferous veggies, mushrooms, herbs, and targeted nutraceuticals help build resilienceWhy exercise is non-negotiable, and how sitting all day harms prostate and metabolic healthThis episode blends heart, science, and practical strategy to help men live longer and better with prostate cancer.Chapters00:00 – Intro02:00 – The “why” behind Dr. Geo's work07:00 – A powerful patient story & legacy12:00 – The 3 buckets of prostate cancer18:00 – Food, fasting & “It Days”23:00 – Exercise, sitting & movement32:00 – Mushrooms, herbs & targeted nutraceuticalsFrom the upcoming Prostate Summit 2.0

"Any time the patient hears the word 'cancer,' they shut down a little bit, right? They may not hear everything that the oncologist or urologist, or whoever is talking to them about their treatment options, is saying. The oncology nurse is a great person to sit down with the patient and go over the information with them at a level they can understand a little bit more. To go over all the treatment options presented by the physician, and again, make sure that we understand their goals of care," ONS member Clara Beaver, DNP, RN, AOCNS®, ACNS-BC, manager of clinical education and clinical nurse specialist at Karmanos Cancer Institute in Detroit, MI, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about prostate cancer treatment considerations for nurses.  Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by November 21, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the treatment of prostate cancer. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 387: Prostate Cancer Screening, Early Detection, and Disparities Episode 373: Biomarker Testing in Prostate Cancer Episode 324: Pharmacology 101: LHRH Antagonists and Agonists Episode 321: Pharmacology 101: CYP17 Inhibitors Episode 208: How to Have Fertility Preservation Conversations With Your Patients Episode 194: Sex Is a Component of Patient-Centered Care ONS Voice articles: Communication Models Help Nurses Confidently Address Sexual Concerns in Patients With Cancer Exercise Before ADT Treatment Reduces Rate of Side Effects Frank Conversations Enhance Sexual and Reproductive Health Support During Cancer Nurses Are Key to Patients Navigating Genitourinary Cancers Sexual Considerations for Patients With Cancer The Case of the Genomics-Guided Care for Prostate Cancer ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (Second Edition) Manual for Radiation Oncology Nursing Practice and Education (Fifth Edition) Clinical Journal of Oncology Nursing articles: Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers Physical Activity: A Feasibility Study on Exercise in Men Newly Diagnosed With Prostate Cancer The Role of the Advanced Practice Provider in Bone Health Management for the Prostate Cancer Population Oncology Nursing Forum articles: An Exploratory Study of Cognitive Function and Central Adiposity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer ONS Guidelines™ for Cancer Treatment–Related Hot Flashes in Women With Breast Cancer and Men With Prostate Cancer Other ONS resources: Biomarker Database (refine by prostate cancer) Biomarker Testing in Prostate Cancer: The Role of the Oncology Nurse Brachytherapy Huddle Card External Beam Radiation Huddle Card Hormone Therapy Huddle Card Luteinizing Hormone-Releasing Hormone Antagonist Huddle Card Sexuality Huddle Card American Cancer Society prostate cancer page National Comprehensive Cancer Network homepage To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org Highlights From This Episode "I think it's important to note that urologists are usually the ones that are doing the diagnosis of prostate cancer and really start that staging of prostate cancer. And the medical oncologists usually are not consulted until the patient is at a greater stage of prostate cancer. I find that it's important to state because a lot of our patients start with urologists, and by the time they've come to us, they're a lot further staged. But once a prostate cancer has been suspected, the patient needs to be staged for the extent of disease prior to that physician making any treatment recommendations. The staging includes doing a core biopsy of the prostate gland. During this core biopsy, they take multiple different cores at different areas throughout the prostate to really look to see what the cancer looks like." TS 1:46 "[For] the very low- and low-risk group, the most common [treatment] is active surveillance. ... Patients can be offered other options such as radiation therapy or surgery if they're not happy with active surveillance. ... The intermediate-risk group has favorable and unfavorable [status]. So, if they're a favorable, their Gleason score is usually a bit lower, things are not as advanced. These patients are offered active surveillance and then either radical prostatectomy with possible removal of lymph nodes or radiation—external beam or brachytherapy. If a patient has unfavorable intermediate risk, they are offered radical prostatectomy with removal of lymph nodes, external radiation therapy plus hormone therapy, or external radiation with brachytherapy. All three of these are offered to patients, although most frequently we see that our patients are taken in for radical prostatectomy. For the high- or very high-risk [group], patients are offered radiation therapy with hormone therapy, typically for one to three years. And then radical prostatectomy with removal of lymph nodes could also be offered for those patients." TS 7:55 "Radiation can play a role in any risk group depending on the patient's preference. ... The types of radiation that we use are external beam, brachytherapy, which is an internal therapy, and radiopharmaceuticals, [which are] more for advanced cancer, but we are seeing them used in prostate [cancer] as well. External beam radiation focuses on the tumor and any metastasis we may have with the tumor. It can be used in any risk [group] and for recurrence if radiation has not been done previously. If a patient has already been radiated to the pelvic area or to the prostate, radiation is usually not given again because we don't want to damage the patient any further. Brachytherapy is when we put radioactive pellets directly into the prostate. For early-stage prostate cancer, this can be given alone. And for patients who have a higher risk of the cancer growing outside the prostate, it can be given in combination with external beam radiation. It's important to note with brachytherapy, it cannot be used on patients who've had a transurethral resection of the prostate or any urinary problems. And if the patient has a large prostate, they may have to be on some hormone therapy prior to brachytherapy, just to shrink that prostate down a little bit to get the best effect. ... Radiopharmaceuticals treat the prostate-specific membrane antigen." TS 11:05 "The side effects of surgery are usually what deter the patient from wanting surgery. The first one is urinary incontinence. A lot of times, a patient has a lot of urinary incontinence after they have surgery. The other one is erectile dysfunction. A lot of patients may not want to have erectile dysfunction. Or, if having an erection is important to the patient, they may not want to have surgery to damage that. In this day and age, physicians have gotten a lot better at doing nerve-sparing surgeries. And so they really do try to do that so that the patient does not have any issues with erectile dysfunction after surgery. But [depending on] the extent of the cancer where it's growing around those nerves or there are other things going on, they may not be able to save those nerves." TS 15:26 "Luteinizing hormone-releasing hormone, or LHRH antagonists or analogs, lower the amount of testosterone made by the testicles. We're trying to stop those hormones from growing to prevent the cancer. ... When we lower the testosterone very quickly, there can be a lot more side effects. But if we lower it a little bit less, we can maybe help prevent some of them. The side effects are important. When I was writing this up, I was thinking, 'Okay, this is basically what women go through when they go through menopause.' We're decreasing the estrogen. We're now decreasing the testosterone. So, the patients can have reduced or absent sexual desire, they can have gynecomastia, hot flashes, osteopenia, anemia, decreased mental sharpness, loss of muscle mass, weight gain, and fatigue." TS 17:50 "What we all need to remember is that no patient is the same. They may not have the same goals for treatment as the physicians or the nurses want for the patient. We talked about surgery as the most common treatment modality that's presented to patients, but it's not necessarily the option that they want. It's really important for healthcare professionals to understand their biases before talking to the patients and the family. It's also important to remember that not all patients are in heterosexual relationships, so we need to explain recovery after treatment to meet the needs of our patients and their sexual relationships, which is sometimes hard for us. But remembering that—especially gay men—they may not have the same recovery period as a heterosexual male when it comes to sexual relationships. So, making sure that we have those frank conversations with our patients and really check our biases prior to going in and talking with them." TS 27:16

In this episode of The Performance Medicine Show, Andy Rogers, PA-C answers YOUR health and wellness questions!What did you think of this episode of the podcast? Let us know by leaving a review!Connect with Performance Medicine!Check out our new online vitamin store:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠https://performancemedicine.net/shop/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sign up for our weekly newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://performancemedicine.net/doctors-note-sign-up/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@PMedicine⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@PerformancemedicineTN⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Performance Medicine

In this heartfelt episode of 20-Minute Health Talk, host Sandra Lindsay delves into the emotional journey of prostate cancer from the unique perspectives of supportive partners. Joining her are two remarkable women, Mary Hillery and Tamara Houston, who share their experiences as caregivers alongside their husbands, prostate cancer survivors Tony Hillery and former New York Knicks player Allan Houston. Mary Hillery, a human resources expert, offers insights on resilience and caregiving. Tamara Houston, an educator and advocate for youth empowerment, speaks on the power of faith and familial support in challenging times. Tune in to hear their powerful testimonies of love, partnership, and unwavering strength. About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 28 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit the health system's job portal and explore our many opportunities.  

Did you know that dogs and most animals almost never get prostate cancer, yet humans do? In this episode, Dr. Stephen Petteruti digs into one of medicine's biggest mysteries and exposes how our current approach may be creating a “pathological tsunami” that leads to more invasive tests and more expensive, patented treatments. From animal biology to overlooked medical history, he breaks down why prostate cancer is nearly unique to humans, the hidden dangers behind routine biopsies, and how conventional medicine may be contributing to the very problem it's trying to solve. If you care about men's longevity, medical truth, or smarter, safer approaches to prostate health, this episode will challenge what you think you know. Tune in to this week's episode of Intellectual Medicine: Can Dogs Get Prostate Cancer? What It Teaches Us About Men's Health.Enjoy the podcast? Subscribe and leave a 5-star review.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives. Website: www.intellectualmedicine.com Website: https://www.theprostateprotocol.com/ YouTube: https://www.youtube.com/@intellectualmedicine LinkedIn: https://www.linkedin.com/in/drstephenpetteruti/ Instagram: instagram.com/intellectualmedine Consultation: https://www.theprostateprotocol.com/book-a-consultation Store: https://www.theprostateprotocol.com/store Community: https://www.theprostateprotocol.com/products/communities/v2/fightcancerlikeaman/home  #ProstateHealth #CancerResearch #BiopsyRisksDisclaimer:The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

Full article: PI-RADS Version 2.1 for Prostate MRI Interpretation: Associations of Study Quality and Cancer Detection Metrics—A Systematic Review and Meta-Analysis Research quality can influence the results of studies evaluating PI-RADS performance. Tobi Folami, MD, discusses this AJR article by Nedelcu et al. reporting a meta-analysis of PI-RADS v2.1 performance, with attention to the impact of study quality.

Treat ADHD, lower Alzheimer's risk?The episode explores emerging evidence that simply having ADD/ADHD raises lifetime Alzheimer's risk—yet appropriately treating it in adults, often with low-dose stimulants, seems to push that risk back down. How can the same class of drugs be both feared as “brain-burning” and yet potentially brain-saving—and what does that mean for people already in midlife?Treating prostate cancer successfully with--testosterone? Listeners are introduced to a first-in-oncology “directed evolution” case in metastatic prostate cancer, led by Dr. Lemanne's team, where high-dose testosterone was deliberately used to expand treatment-sensitive cells—and only then was hormone blockade re-introduced. But did this radical, counterintuitive maneuver actually work?Emotional trauma in youth as a hidden Alzheimer's driver? Dr. Gordon discusses links between youth emotional trauma to higher rates of Alzheimer's decades later, even in people who appear to have “moved on.” Is this just correlation, or should early emotional trauma be considered a subtle form of brain injury that can and should be addressed?Do you go to bed later on weekends, by just 1-2 hours, but make up for it by rising later?  If so, you'll want to know that you may be increasing your risk of breast or prostate cancer.  This episode explores that research.Have you heard of the new Alzheimer's blood tests, that improve as the patient improves, allowing better direction of treatment? Dr. Gordon walks us through the ATN panel (amyloid-beta, p-tau, neurofilament light), now accessible through routine laboratory tests, along with galectin-3 as a tau-clustering, inflammation-linked marker, and a new infusion drug (TB006) targeting that pathway. But can these numbers really be moved in the right direction with targeted lifestyle and medical interventions—and what happens when they are?Enjoy this unusual episode! And write to us. We read every email.Dawn Lemanne, MD Oregon Integrative OncologyLeave no stone unturned.Deborah Gordon, MDNorthwest Wellness and Memory CenterBuilding Healthy Brains

Morning Prayer (people with heart disease, colon cancer, prostate cancer) #prayer #morningprayer #pray #jesus #god #holyspirit #aimingforjesus #healing #peace #love #bible #heart #heartdisease #colon #prostate #coloncancer #prostatecancerThank you for listening, our heart's prayer is for you and I to walk daily with Jesus, our joy and peace aimingforjesus.com YouTube Channel https://www.youtube.com/@aimingforjesus5346 Instagram https://www.instagram.com/aiming_for_jesus/ Threads https://www.threads.com/@aiming_for_jesus X https://x.com/AimingForJesus Tik Tok https://www.tiktok.com/@aiming.for.jesus

About one in eight men will be diagnosed with prostate cancer in their lifetime. What are some diet and lifestyle solutions?

We are delighted to host Nicolas Ronco on this episode of the Mangu.tv podcast series. Nicolas is a global entrepreneur and wellness visionary, with over 25 years of experience spanning wellness, hospitality, technology and media. Founder of YeloSpa, he pioneered an urban sanctuary concept, combining sleep therapy, reflexology, and design, establishing a global benchmark for modern wellness with locations in New York, São Paulo, and San Joan. Previously, he held leadership roles at Time Warner, Trader Classified Media, and Make Music Inc., driving innovation and generating significant revenue growth.  Nicolas has also advised top brands through Groups of Humans and Hope.Tech. Vice Chair of the Immersion Initiative at the Global Wellness Institute, he champions holistic wellbeing worldwide. Educated in Paris and New York, and fluent in three languages, he continues to guide global wellness ventures with cultural and business insights.Nicolas shares the story of his upbringing in Tunisia, with Jewish & Italian heritage and his education in Paris. He speaks about a mystical experience that happened to him whilst living in New York, following a visit to Guru Mai's ashram, and the impact it had on his life. He shares his first experience with psychedelics later on in life, in Alto Paraiso. Nico talks about his relationships, his struggles with prostate cancer and the benefits he gained from psychedelics. Giancarlo and Nico discuss attachment styles, reincarnation, and altered states of consciousness.

116 Clare men face a prostate cancer diagnosis each year, according to National Cancer Registry of Ireland - and half of those who undergo prostate cancer treatment will go on to experience urinary incontinence (UI). These figures form the backdrop to the launch of ‘Dispose with Dignity', a new campaign from hygiene services company PHS Group, supported by the Irish Cancer Society and the Irish Men's Sheds Association. The initiative aims to break the stigma surrounding male incontinence and improve access to hygiene facilities, such as sanitary bins and vending products, in men's public toilets nationwide. New research released as part of the campaign reveals that a lack of suitable toilet facilities and low awareness about male urinary incontinence (UI) are having a serious impact on men's mental health and daily lives. John Wall, healthcare campaigner who's living with Stage 4 Metastatic Prostrate Cancer spoke with Alan Morrissey on Thursday's Morning Focus. Photo (c) pixelshot via Canva.com

What do patients really think about prostate cancer care? Is it true that 50% of men are still being undertreated? Credit available for this activity expires: 11/12/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-personalized-care-prostate-cancer-patient-centered-2025a1000uyb?ecd=bdc_podcast_libsyn_mscpedu

Featuring perspectives from Dr Emmanuel S Antonarakis and Dr Matthew R Smith, including the following topics:  Introduction (0:00) Optimizing the Role of Hormonal Therapy in the Care of Patients with Prostate Cancer — Dr Smith (0:55) Available and Emerging Therapeutic Approaches for Metastatic Castration-Resistant Prostate Cancer — Dr Antonarakis (26:37) CE information and select publications

Dr Emmanuel S Antonarakis and Dr Matthew R Smith share their perspectives on the evolving therapeutic landscape for patients with prostate cancer. CME information and select publications here.

The More Sibyl Podcast Presents: 잘 세워진 남자| The One with Dr. Timi Adepoju On Becoming a Well-Built Man: Faith, Balance, and the Architecture of Leadership| Episode 33 (2025)To close out our Prostate Cancer & Men's Wellness Awareness Series, we sit with Dr. Timi Adepoju, a physician, leadership coach, entrepreneur, and living proof that adversity can be a launchpad.From growing up in Ibadan during Nigeria's era of scarcity to building thriving clinics and leadership programs in the U.S., his story is a masterclass in grit, grace, and growth. He reflects on how childhood lessons, faith, and a “make the most of what you have” mindset shaped the man he is today and why he refused to abandon his dream of becoming a physician, even when others urged him to take an easier road.But this conversation isn't just about achievement. It's a full reset on men's wellness and balance; a candid look at why men around the world are dying younger, how the “provider” mindset fuels silent exhaustion, and why rest, nutrition, yearly checkups, and breathing space are not indulgences, but survival tools.Dr. Adepoju shares his own transformation from 100-hour workweeks to building rhythms of rest, intentional vacations, and sustainable balance. For leaders and multitaskers, his thoughts on clarity, structure, and letting go will resonate deeply: how to create systems, trust your team, set weekly anchors, and accept that the world will keep spinning even when you take a day off.We also explore how he built Empower Children's Clinic in Mississippi by turning barriers into blueprints — seeing poverty, health disparities, and limited pediatric access as opportunities to serve. “Light comes out of darkness,” he says, and his clinics, now in multiple locations, prove it.In the end, we return to what greatness truly means. Vulnerability. Accountability. The courage to grow and evolve year after year. If you're a physician with a vision, a man redefining strength, or anyone learning to balance ambition with well-being, this episode will both ground and inspire you.Tune in to hear the full conversation; available now on all podcast streaming platforms.

A San Antonio scientist thinks of the protein that drives most prostate cancers as a machine, and pioneers a method to visualize it for the first time. This could lead to much better treatments and, someday, prevention.

Brian leads a discussion of Rana McCay, Chris Sweeney and Michael Morris on the PSMAddition data and the landscape of radioligands in prostate cancer.

November is prostate cancer awareness month in Sweden with the prostate cancer society running its' blue moustache campaign using women bikers to shed light on the most common cancer among men in Sweden. We hear from Sweden's intelligence service Säpo after prosecutors announced they've charged an 18-year-old with planning a suicide bomb attack which would have targeted a large music and arts festival which takes place in central Stockholm.We're also discussing the latest cooperation agreement between Sweden and Ukraine and hear about Alexander Skarsgård who'll be appearing at the Stockholm International Film Festival.Presenters: Dave Russell and Michael Walsh.Producer: Kris Boswell

Study: Mitopure's impact on immune parametersWhat important blood tests should one get, and what are the ideal levels to look for?I do coffee enemas for liver detox. How many can I do per week?  I've been on Metformin and lost some weight. Should I increase my dose to lose more?Could a recent dental implant be causing clogged ears and a hissing noise?

More on gadolinium effects and detoxI was found to have a small pericardial effusion. What advice can you give me?Is melatonin beneficial for bone mineral density? If so, how much should I take?

Prostate cancer is one of the most common cancers in men. While treatment options have improved, advanced stages of the disease remain difficult to manage. One promising approach involves a process called ferroptosis. This is a type of programmed cell death that relies on iron and lipid oxidation to kill cancer cells by damaging specific fats in their outer membrane. These fats are especially vulnerable in environments with normal oxygen levels. However, many prostate tumors grow in low-oxygen areas of the body, a condition known as hypoxia, where ferroptosis becomes less effective. A recent study, titled “Hypoxia induced lipid droplet accumulation promotes resistance to ferroptosis in prostate cancer,” and published on Oncotarget (Volume 16), explores how oxygen-poor environments help prostate cancer cells resist treatment and what strategies could help overcome this resistance. Full blog - https://www.oncotarget.org/2025/11/06/how-low-oxygen-shields-prostate-cancer-from-ferroptosis-therapies/ Paper DOI - https://doi.org/10.18632/oncotarget.28750 Correspondence to - Noel A. Warfel - warfelna@arizona.edu, and Shailender S. Chauhan - shailenderc@arizona.edu Abstract video - https://www.youtube.com/watch?v=xFypDT4ALmc Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28750 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, hypoxia, lipid droplets, ferroptosis, resistance, prostate To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

If it drains your energy and damages your prostate, it's not medicine, it's harm.In this episode, Dr. Stephen Petteruti continues to expose how conventional prostate treatments can do more damage than good. He shares the science-backed supplements and lifestyle choices that truly support long-term vitality.From potent nutraceuticals like broccoli powder, diindolylmethane (DIM), lycopene, N-acetylcysteine (NAC), and pomegranate extract, you'll learn how to strengthen your immune system, slow cancer progression, and nourish your prostate naturally.Dr. Petteruti's core message: take personal responsibility for your health, protect your energy, and live each day with strength, vitality, and purpose.Take charge of your prostate health. Tune in to this episode of Supplements for Prostate Cancer: What Works, What Doesn't, and What's Harmful (Part 2).Enjoy the podcast? Subscribe and leave a 5-star review.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives.Website: www.intellectualmedicine.com Website: https://www.theprostateprotocol.com/ YouTube: https://www.youtube.com/@intellectualmedicine LinkedIn: https://www.linkedin.com/in/drstephenpetteruti/ Instagram: instagram.com/intellectualmedine Consultation: https://www.theprostateprotocol.com/book-a-consultation Store: https://www.theprostateprotocol.com/store Community:https://www.theprostateprotocol.com/products/communities/v2/fightcancerlikeaman/home Disclaimer:The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by: https://www.broadcastyourauthority.com/

Matt Rooney, Founder and Editor-in-Chief of SaveJersey.comTopic: New Jersey Gubernatorial Race John Solomon, award-winning investigative journalist, founder of "Just The News," and the host of “Just the News, No Noise” on the Real America’s Voice network Topic: Elections around the country Lenny Caro, President of the Yonkers Chamber of Commerce Topic: Celebrating Yonkers Col. Jack Jacobs, a retired colonel in the United States Army and a Medal of Honor recipient for his actions during the Vietnam War Topic: Latest U.S. military strike on an alleged drug cartel boat Joe Borelli, Former New York City Councilman and Managing Director of Chartwell Strategy GroupTopic: New York City Mayoral Race Mike Connors, Attorney at Law at Connors & Sullivan and host of "Ask the Lawyer," airing Saturdays at 6 p.m. and Sundays at 11 a.m. on AM 970 The AnswerTopic: Estate Planning Gone Wrong Jim McLaughlin, pollster, strategic consultant, and CEO and Partner of McLaughlin & AssociatesTopic: Polling in New York and New Jersey races Mike Davis, Founder of the Article III Project, Former Law Clerk for Justice Neil Gorsuch, and Former Chief Counsel for Nominations for the U.S. Senate Committee on the JudiciaryTopic: "Justice is coming for perpetrators of Arctic Frost" (Fox News op ed) Dr. Gil Lederman, Expert in Prostate Cancer and the host of "Radiosurgery New York with Dr. Gil Lederman" on AM 970 The AnswerTopic: Jewish tourist attacked in New York CitySee omnystudio.com/listener for privacy information.

According to the American Cancer Society, prostate cancer is the most common cancer among men. Data also suggests there are huge racial disparities when it comes to prostate cancer diagnoses, treatment, and outcomes. “Closer Look” program host Rose Scott talks with Reggie Hicks, the executive producer of the documentary film and host of the podcast "If You Are My Brothers." Hicks talks about his efforts to spread awareness through the documentary and podcast, as well as his ongoing fight against the disease. Plus, the story of Dr. Karen Kinsell of Clay County Medical Center was the focus of “The Only Doctor” documentary. For more than 13 years, she was the only medical doctor in Clay County, Georgia. Dr. Kinsell joins “Closer Look” to talk more about how things have changed since she’s no longer the only doctor in Clay County, as well as her new efforts to transform dilapidated houses into affordable housing.See omnystudio.com/listener for privacy information.

I recently had an ApoB test and am surprised that it isn't lower than it is.  Can you explain?I have an ascending thoracic aortic aneurysm.  How can I keep it from enlarging?Why are you against whole-body scans? Aren't they helpful?Can I take magnesium L-threonate while also taking magnesium glycinate?

Will Truheight vitamins really make your kids grow?Where can I learn more about complementary medicine and nutrition?The balls of my feet are sore along with my toes. Is this a vitamin deficiency?

Host: Darryl S. Chutka, M.D. Guest: Daniel M. Frendl, M.D., Ph.D. Prostate cancer is quite common in middle age and older men and represents the second most common malignancy diagnosed in this population. Only skin cancer is more common. Early diagnosis is important and carries an excellent prognosis. There are several management options available for localized disease and some new treatments which can be used for both aggressive and more advanced disease. When should active surveillance be used when prostate cancer has been diagnosed? How does radiation therapy compare to surgical prostatectomy regarding long-term outcomes and what are some of the newer treatment options available for advanced disease? These are some of the questions I'll be asking my guest, Daniel M. Frendl, M.D., Ph.D., a urologist from the Department of Urology at the Arizona campus of the Mayo Clinic as we discuss “Prostate Cancer”. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

The More Sibyl Podcast Presents: 깊은 믿음의 자리| The One with Mr. Mark Harris on Breaking the Silence on Prostate Cancer | Episode 32 (2025)In this episode, I sit down with Mr. Mark Harris, a men's health advocate whose story redefines what it means to face illness with faith, courage, and community.Recorded on Father's Day, this conversation goes beyond prostate cancer; it's about legacy, love, and learning to “do it afraid.” Mr. Harris opens up about his prostate cancer diagnosis, the heartbreaking loss of his son to a rare cancer, and how both experiences shaped his mission to help men speak up, get checked, and live fully.From the power of early detection to breaking the silence around men's health, Mr. Harris reminds us that strength and softness can coexist, and that sharing your story doesn't make you weak; it makes you a guide for others finding their strength.

Host: Darryl S. Chutka, M.D. Guest: Daniel M. Frendl, M.D., Ph.D. If your practice includes middle age and older men, you've very likely diagnosed prostate cancer. It's the most diagnosed non-skin cancer in men in the U.S. Its incidence rises with age, with a median age of around 66 years. When found early, prostate cancer is very treatable, and in most cases, curable. Prostate specific antigen, or PSA is very effective in detecting early prostate cancer, but its use has been controversial due to the risk of overdiagnosis and overtreatment. What are the current recommendations for prostate cancer screening with PSA? What's the role of the digital rectal exam? How should we be using the PSA and what other tests are available for prostate cancer screening? The topic for this podcast is “Prostate Cancer Screening” and I'll be asking these questions to my guest, Daniel M. Frendl, M.D., Ph.D., a urologist at the Arizona campus of the Mayo Clinic. Tune in this Thursday for our next episode on "Prostate Cancer" releasing October 30, 2025. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts